
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Walgreens is heading down a risky path
Walgreens has been attempting a financial turnaround for years, and now it says it’s found a new path to finish it. But if history is any guide, its path is more likely to lead to its eventual demise than long-term success.

‘Not medically necessary’: Inside the company helping America’s biggest health insurers deny coverage for care
Every day, patients across America crack open envelopes with bad news. Yet another health insurer has decided not to pay for a treatment that their doctor has recommended. Sometimes it’s a no for an MRI for a high school wrestler with a strained back. Sometimes for a cancer procedure that will help a grandmother with a throat tumor. Sometimes for a heart scan for a truck driver feeling short of breath.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.